Volker J J Schettler (Volker Jj Schettler, Volker Schettler)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Mesenchymal Stem Cells

Clinical Practice

Ejection Fraction

Top Venues

Advances in therapy

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Lehrke, Anja Vogt, Volker J J Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N Dhalwani, Kausik K Ray
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Advances in therapy 41 (3) (2024)
Michael Lehrke, Anja Vogt, Volker J J Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N Dhalwani, Kausik K Ray
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Advances in therapy 41 (3) (2024)
Michael Lehrke, Anja Vogt, Volker J J Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N Dhalwani, Kausik K Ray
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Advances in therapy 41 (3) (2024)
Michael Lehrke, Anja Vogt, Volker J J Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N Dhalwani, Kausik K Ray
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Advances in therapy 41 (3) (2024)
Sophie Schröder, Robert Epple, Andre Fischer, Volker J J Schettler
Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2024)
Michael Lehrke, Anja Vogt, Volker J J Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N Dhalwani, Kausik K Ray
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Advances in therapy (2024)
Michael Lehrke, Anja Vogt, Volker J J Schettler, Matthias Girndt, Uwe Fraass, Anja Tabbert-Zitzler, Ian Bridges, Nafeesa N Dhalwani, Kausik K Ray
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Advances in therapy 41 (3) (2024)
Volker J J Schettler, Elke Schettler
Beyond cholesterol-pleiotropic effects of lipoprotein apheresis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)
Volker J J Schettler, Christian Peter, Thomas Zimmermann, Ulrich Julius, Eberhard Roeseler, Georg Schlieper, Franz Heigl, Peter Grützmacher, Iris Löhlein, Reinhard Klingel, Bernd Hohenstein, Wolfgang Ramlow, Anja Vogt, null null
The German Lipoprotein Apheresis Registry-Summary of the ninth annual report. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)
Bernd Hohenstein, Volker J J Schettler, Kirsten de Groot
With reasonable doubt: Plasma exchange in PEXIVAS. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 25 (1) (2020)
Volker J J Schettler, Florian Muellendorff, Elke Schettler, Christina Platzer, Sabine Norkauer, Ulrich Julius, Claas-Lennart Neumann
NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study). Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 23 (5) (2019)